This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio X Cell
product type :
antibody
product name :
InVivoMab anti-mouse VEGFR-2
catalog :
BE0060
quantity :
5 mg
price :
300 USD
clonality :
monoclonal
host :
rat
conjugate :
nonconjugated
clone name :
DC101
reactivity :
mouse
citations: 11
Reference
Huang Y, Lan Q, Ponsonnet L, Blanquet M, Christofori G, Zaric J, et al. The matricellular protein CYR61 interferes with normal pancreatic islets architecture and promotes pancreatic neuroendocrine tumor progression. Oncotarget. 2016;7:1663-74 pubmed publisher
Lee H, Yoon C, Park D, Kim Y, Schmidt B, Lee Y, et al. Inhibition of vascular endothelial growth factor A and hypoxia-inducible factor 1α maximizes the effects of radiation in sarcoma mouse models through destruction of tumor vasculature. Int J Radiat Oncol Biol Phys. 2015;91:621-30 pubmed publisher
Arulanandam R, Batenchuk C, Angarita F, Ottolino-Perry K, Cousineau S, Mottashed A, et al. VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection. Cancer Cell. 2015;28:210-24 pubmed publisher
Ding X, Lucas T, Marcuzzi G, Pfister H, Eming S. Distinct functions of epidermal and myeloid-derived VEGF-A in skin tumorigenesis mediated by HPV8. Cancer Res. 2015;75:330-43 pubmed publisher
Larrayoz M, Pio R, Pajares M, Zudaire I, Ajona D, Casanovas O, et al. Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype. EMBO Mol Med. 2014;6:539-50 pubmed publisher
Kizhatil K, Ryan M, Marchant J, Henrich S, John S. Schlemm's canal is a unique vessel with a combination of blood vascular and lymphatic phenotypes that forms by a novel developmental process. PLoS Biol. 2014;12:e1001912 pubmed publisher
Kim Y, Lee H, Kim T, Eisinger-Mathason T, Zhang A, Schmidt B, et al. Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α. Int J Cancer. 2013;132:29-41 pubmed publisher
Villalta S, Lang J, Kubeck S, Kabre B, Szot G, Calderon B, et al. Inhibition of VEGFR-2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet function. Diabetes. 2013;62:2870-8 pubmed publisher
Kilarski W, Samolov B, Petersson L, Kvanta A, Gerwins P. Biomechanical regulation of blood vessel growth during tissue vascularization. Nat Med. 2009;15:657-64 pubmed publisher
Kumar V, Scandella E, Danuser R, Onder L, Nitschké M, Fukui Y, et al. Global lymphoid tissue remodeling during a viral infection is orchestrated by a B cell-lymphotoxin-dependent pathway. Blood. 2010;115:4725-33 pubmed publisher
Chatterjee S, Wang Y, Duncan M, Naik U. Junctional adhesion molecule-A regulates vascular endothelial growth factor receptor-2 signaling-dependent mouse corneal wound healing. PLoS ONE. 2013;8:e63674 pubmed publisher
product information
Catalog Number :
BE0060
Product Name :
InVivoMab anti-mouse VEGFR-2
Host Species :
rat
Clonality :
monoclonal
Product Type :
antibody
Size :
5 mg
List Price :
450
Acedemic Discount Price :
300 USD
Clone :
DC101
Isotype :
IgG1
Specificity :
mouse
Application Summary :
in vivo blocking of VEGF/VEGFR-2 signaling, in vitro blocking of VEGFR signaling
company information
Bio X Cell
10 Technology Dr., Suite 2B
Lebanon, NH 03784-1671
customerservice@bxcell.com
bxcell.com
1-866-787-3444
headquarters: USA